Biodesix, Inc. BDSX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -26%+17.8pp | -31.5%+16.9pp | -40.6%+12.4pp | -44.5%+10.1pp | -43.8%+21.8pp | |
| Net margin | -33.3%+21.0pp | -39.8%+20.3pp | -49.3%+17.5pp | -53.7%+19.4pp | -54.3%+31.5pp | |
| Returns | ||||||
| Return on equity | -316.5%— | —— | —— | -219.7%— | —— | |
| Return on invested capital | -45%+20.3pp | -51.6%+20.6pp | -57.6%+21.5pp | -63%+24.4pp | -65.3%+50.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.2× | 1×+0.2× | 0.8×+0.1× | 0.8×+0.1× | 0.9×+0.2× | |
| Liquidity | ||||||
| Current ratio | 2.8×+0.6× | 1.9×-0.9× | 1.8×-1.6× | 2.1×-1.1× | 2.2×+1.3× | |
| Leverage | ||||||
| Debt-to-equity | 7.8×+2.2× | —— | —— | 63.4×+61.7× | 5.6×— | |
| Per Share | ||||||
| Book value per share | $0.95-37.6% | -$0.33-110% | -$0.23-106% | $0.01-97.3% | $1.52+2,777% | |
| Valuation | ||||||
| Market capitalization | $233.52M+476% | $54.1M-75.7% | $60.4M-76.8% | $40.33M-79.3% | $91.27M-34.3% | |
| Price / sales | 2.4×+1.9× | 0.6×-2.5× | 0.8×-3.2× | 0.5×-2.7× | 1.2×-1.3× | |
| Price / book | 25.6×-10.1× | —— | —— | 35.4×+30.1× | 8.3×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biodesix, Inc.'s ratios come from?
- Every ratio is computed from Biodesix, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
